Standard
Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen. / Engsig, Frederik N; Gerstoft, Jan; Kronborg, Gitte; Larsen, Carsten Schade; Pedersen, Gitte; Audelin, Anne M; Jørgensen, Louise B; Obel, Niels; Jørgensen, Louise B.
I:
Clinical Epidemiology, Bind 2, 01.01.2010, s. 145-51.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Engsig, FN, Gerstoft, J, Kronborg, G, Larsen, CS, Pedersen, G, Audelin, AM, Jørgensen, LB, Obel, N & Jørgensen, LB 2010, 'Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen', Clinical Epidemiology, bind 2, s. 145-51.
APA
Engsig, F. N., Gerstoft, J., Kronborg, G., Larsen, C. S., Pedersen, G., Audelin, A. M., Jørgensen, L. B., Obel, N., & Jørgensen, L. B. (2010). Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen. Clinical Epidemiology, 2, 145-51.
Vancouver
Engsig FN, Gerstoft J, Kronborg G, Larsen CS, Pedersen G, Audelin AM o.a. Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen. Clinical Epidemiology. 2010 jan. 1;2:145-51.
Author
Engsig, Frederik N ; Gerstoft, Jan ; Kronborg, Gitte ; Larsen, Carsten Schade ; Pedersen, Gitte ; Audelin, Anne M ; Jørgensen, Louise B ; Obel, Niels ; Jørgensen, Louise B. / Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen. I: Clinical Epidemiology. 2010 ; Bind 2. s. 145-51.
Bibtex
@article{abe6220d8b05464bbdebd5215b963c9a,
title = "Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen",
abstract = "Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses.",
author = "Engsig, {Frederik N} and Jan Gerstoft and Gitte Kronborg and Larsen, {Carsten Schade} and Gitte Pedersen and Audelin, {Anne M} and J{\o}rgensen, {Louise B} and Niels Obel and J{\o}rgensen, {Louise B}",
year = "2010",
month = jan,
day = "1",
language = "English",
volume = "2",
pages = "145--51",
journal = "Clinical Epidemiology",
issn = "1179-1349",
publisher = "Dove Medical Press Ltd",
}
RIS
TY - JOUR
T1 - Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen
AU - Engsig, Frederik N
AU - Gerstoft, Jan
AU - Kronborg, Gitte
AU - Larsen, Carsten Schade
AU - Pedersen, Gitte
AU - Audelin, Anne M
AU - Jørgensen, Louise B
AU - Obel, Niels
AU - Jørgensen, Louise B
PY - 2010/1/1
Y1 - 2010/1/1
N2 - Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses.
AB - Raltegravir is the first integrase inhibitor approved for treatment of HIV-infected patients harboring multiresistant viruses.
M3 - Journal article
VL - 2
SP - 145
EP - 151
JO - Clinical Epidemiology
JF - Clinical Epidemiology
SN - 1179-1349
ER -
